Copernicus Capital Management
Latest statistics and disclosures from Copernicus Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PFE, TMO, TDOC, BMRN, JNJ, and represent 60.26% of Copernicus Capital Management's stock portfolio.
- Added to shares of these 10 stocks: PFE, TMO, TDOC, BMRN, JNJ, ALLO, MDT, PRQR, IMTX, FATE.
- Started 10 new stock positions in JNJ, IMTX, FOLD, PRQR, TMO, PFE, ALLO, BMRN, MDT, TDOC.
- Reduced shares in these 9 stocks: , Atara Biotherapeutics, ZNTL, Tcr2 Therapeutics Inc cs, ACCD, , GRTSQ, SKIN, RCUS.
- Sold out of its positions in ACCD, Atara Biotherapeutics, GRTSQ, Tcr2 Therapeutics Inc cs, SKIN, VRTX, ZNTL, JAZZ.
- Copernicus Capital Management was a net buyer of stock by $1.6M.
- Copernicus Capital Management has $8.3M in assets under management (AUM), dropping by 30.31%.
- Central Index Key (CIK): 0001694620
Tip: Access up to 7 years of quarterly data
Positions held by Copernicus Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Copernicus Capital Management
Copernicus Capital Management holds 13 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Pfizer (PFE) | 15.6 | $1.3M | NEW | 30k | 43.00 |
|
| Thermo Fisher Scientific (TMO) | 13.8 | $1.1M | NEW | 2.0k | 571.50 |
|
| Teladoc (TDOC) | 10.7 | $888k | NEW | 7.0k | 126.86 |
|
| BioMarin Pharmaceutical (BMRN) | 10.3 | $850k | NEW | 11k | 77.27 |
|
| Johnson & Johnson (JNJ) | 9.8 | $808k | NEW | 5.0k | 161.60 |
|
| Fate Therapeutics (FATE) | 8.6 | $711k | +20% | 12k | 59.25 |
|
| Horizon Therapeutics Pub L SHS | 8.0 | $657k | +20% | 6.0k | 109.50 |
|
| Arcus Biosciences Incorporated (RCUS) | 7.2 | $593k | -15% | 17k | 34.88 |
|
| Allogene Therapeutics (ALLO) | 4.7 | $386k | NEW | 15k | 25.73 |
|
| Medtronic SHS (MDT) | 4.6 | $376k | NEW | 3.0k | 125.33 |
|
| Proqr Thrapeutics N V Shs Euro (PRQR) | 4.1 | $335k | NEW | 40k | 8.38 |
|
| Immatics SHS (IMTX) | 1.6 | $130k | NEW | 10k | 13.00 |
|
| Amicus Therapeutics (FOLD) | 1.2 | $96k | NEW | 10k | 9.60 |
|
Past Filings by Copernicus Capital Management
SEC 13F filings are viewable for Copernicus Capital Management going back to 2017
- Copernicus Capital Management 2021 Q3 filed Nov. 15, 2021
- Copernicus Capital Management 2021 Q2 filed Aug. 16, 2021
- Copernicus Capital Management 2021 Q1 filed May 17, 2021
- Copernicus Capital Management 2020 Q4 filed Feb. 16, 2021
- Copernicus Capital Management 2020 Q3 filed Nov. 16, 2020
- Copernicus Capital Management 2020 Q2 filed Aug. 14, 2020
- Copernicus Capital Management 2020 Q1 filed May 14, 2020
- Copernicus Capital Management 2019 Q4 filed Feb. 14, 2020
- Copernicus Capital Management 2019 Q3 filed Nov. 14, 2019
- Copernicus Capital Management 2019 Q2 filed Aug. 14, 2019
- Copernicus Capital Management 2019 Q1 filed May 15, 2019
- Copernicus Capital Management 2018 Q4 filed Feb. 14, 2019
- Copernicus Capital Management 2018 Q3 filed Nov. 7, 2018
- Copernicus Capital Management 2018 Q2 filed Aug. 14, 2018
- Copernicus Capital Management 2018 Q1 filed May 1, 2018
- Copernicus Capital Management 2017 Q4 filed Feb. 14, 2018